Sentence examples for insomnia up from inspiring English sources

Work, work, work -- bouts of insomnia, up at 2 a.m. thinking about work, showering while thinking about work, skipping breakfast to get to work sooner.

Insomnia affects up to half of all people – with up to 20% having a serious problem with getting off to sleep (or falling asleep again if they wake up).

When insomnia came up, Slimani said, "One writer I know told me that a genius way to put yourself back to sleep is to think of your enemies and how you'd murder them".

Midwinter insomnia affects up to 80% of certain populations at higher latitudes.

To evaluate the probability of a linear relationship between headache frequency at baseline and insomnia at follow up, we performed trend analyses by treating frequency of headache (three categories) as a single ordinal variable.

In line with the present results, there is one study of 437 participants [8] that reported that unspecified bodily pain was a risk factor for new-onset insomnia at follow-up 1 year later.

In age-, sex-, GI-complaints and total HADS score adjusted analyses, CMSCs at baseline was associated with a 2-fold risk of insomnia at follow-up (OR = 1.8; 95% CI = 1.6 – 1.9) compared to subjects without headache and CMSCs.

The only study that included subjects free of sleep disturbance (n = 437) at baseline, reported that unspecified bodily pain was a risk factor for new-onset insomnia at follow-up one year later [8].

In this large-scale prospective study we found that headache and CMSCs increased the risk of insomnia at follow-up, most evident among those with headache ≥ 7 days/month, widespread CMSCs and the co-occurrence of headache and CMSCs at baseline.

In the population at risk, we used multivariate logistic regression (with 95% confidence intervals [CI]) to evaluate the relative influence of headache, CMSCs (alone or in combination with each other) in HUNT 2 on the risk of insomnia at follow-up.

Prescription of hypnotics showed some evidence of association with persistence of insomnia at follow-up (OR 3.18; 95% CI 0.93, 10.92).